Ayurvedic management of Ksheena Shukra - A Case Study
Abstract
Male infertility has gotten less attention, despite its widespread coverage. A demographic survey found that males alone contribute 40-50%. Infertility management in modern medicine has limitations and drawbacks. Furthermore, it can only guarantee 30 to 40% results. It is quite expensive, and the average person cannot afford it. Low sperm count (oligospermia) and increased immotility of sperms (asthenospermia) is the main causes of male infertility and it can be correlated with Shukravaha Srotas Dushti and is a problem of global proportions. Worldwide infertility is affecting on an average 8-12% of couples. Acharya Sushrut has explained 10 types of Shukra Dushti which are incapable of producing a progeny. Shukravaha Srotas Dushti leads to Aharsha, Klaibya etc. there is no direct correlation of oligospermia but we can correlate it with Shukra Kshaya or Ksheena Shukra. A 28-year-old male who had been diagnosed as Oligonecrospermia with increased immotile sperm with 02 years of married life and his wife with regular menstrual cycle, were treated successfully with Ayurvedic management. After Aamapachana, the patient was given Shamana chikitsa (tab Addyzoa charak pharmacy, Chandraprabha vati, Gokshuradi guggulu, Narasimha Rasayana, Punarnavasava).
Downloads
References
Zegers-Hochschild F, Adamson GD, de Mouzon J, Ishihara O,
Mansour R, Nygren K, Sullivan E, and Van der Poel S. The ICMART and WHO revised their glossary of ART terminology in 2009. Human Reproduction, 2009, 24(11):2683-7.
Kumar P, Jeffcoate SN, Malhotra N. "Jeffcoate's Principles of Gynaecology." 7th Edition. Butterworth's, New Delhi. 2008;985.
Sciarra J. Infertility: An International Health Concern. International Journal of Gynecology & Obstetrics, 1994; 46(2): 155-63.
Jr, BFP; Federico R. Tewes. Attorneys should understand Medicare set-aside allocations. How Medicare Set-Aside Allocation will speed up settlements in catastrophic personal injury cases. Clinical Medicine and Medical Research. 2021;2(1):61-64.
Padubidri; D. Shaw's Textbook of Gynaecology, Elesiver publishers 15e. 2011.pp. 204.
Sharma PV, editor. Shukrashonita Shuddhi.Shari Ram Adhyaya. Chapter II, Verse 3. Source: Sushruta Samhita, Sharira Sthana. Varanasi, India: Chaukhamba Vishvabharati; 2005; 18.
Acharya YT, Susruta Samhita of Sushruta with Nibandha sangraha commentary, Sutrastana 15/9, Chaukhamba Orientalia, Page:1997.pp.69
Acharya YT, Carakasamhita by Agnivesa with Ayurveda dipika commentery, Sutrastana 17/69, Varanasi, Chowkhamba Krishnadas Academy, 2015.pp.103
Sharma PV,editor.ShukrashonitashuddhiShariramAdhyaya.Chapter II, Verse 4. In: Sushruta Samhita and Sharira Sthana. Varanasi, India: Chaukhamba Vishvabharati, 2005;18.
Vd Yadavji Trikamaji Acharya, Agnivesha, Charaka Samhita, with Ayurveda Dipika Commentary by Chakrapani, Chikitsasthan, chapter 1, pada 1, shloka 25-28, Chaukhamba Publication New Delhi. Reprint 2018, Pg. No. 377.
Available_https___www.ayurtimes.com_addy%20zoa_%20[Last%20accessed%20on%2025%20Jul,%202020%20at%2003_25%20-%20Google%20Search.html
Tripati B.,Madhyama khanda chapter 7 verse 84-87,Sharangadhara Samhita of Pandit Sharangadhara Acharya with deepika – Hindi commentary reprint,Varanasi : Chaukhamba Surbhavati Prakashan;2011.p.206.
Bakoliya, Prem & N., Saismitha & K.S, Sakhitha & Yadav, Subhash. (2023). A CRITICAL REVIEW OF THE THERAPEUTIC POTENTIAL OF NARASIMHA RASAYANA. International Journal of Research in Ayurveda and Pharmacy. 14. 83-89. 10.7897/2277-4343.1404119. narasimha Rasayana citation

Copyright (c) 2025 Mohan Kumar S S, Pramod Kapoor, Durgesh Kumar, Atal Bihari Trivedi

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Journal of Ayurveda and Integrated Medical Sciences (JAIMS) retains the copyright of the contents of this journal but grant the readers the right to use the contents with terms and conditions under a creative common attribution licenses 4 of Attribution, Share Alike and Non-commercial type (CC BY-NC-SA) that allows copy, distribute, display, and perform the work and make derivative works based on it only for non-commercial purposes.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.